Aspiriant, LLC Schwab Strategic Tr Us Small C Transaction History

Aspiriant, LLC

$2.45 Billion
Q2 2024

A detailed history of Aspiriant, LLC transactions in Schwab Strategic Tr Us Small C stock. As of the latest transaction made, Aspiriant, LLC holds 5,623 shares of SCHA stock, worth $289,134. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,623

Previous 5,470 2.8%

Holding current value

$289,134

Previous $269,000 1.12%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$45.24 - $49.04 $6,921 - $7,503	153 Added 2.8%	5,623 $266,000
Q1 2024 Apr 15, 2024	SELL	$44.84 - $49.24 $29,280 - $32,153	-653 Reduced 10.66%	5,470 $269,000
Q4 2023 Jan 26, 2024	BUY	$38.13 - $48.02 $21,848 - $27,515	573 Added 10.32%	6,123 $289,000
Q3 2023 Oct 17, 2023	SELL	$40.85 - $46.1 $1,143 - $1,290	-28 Reduced 0.5%	5,550 $229,000
Q2 2023 Jul 19, 2023	SELL	$39.91 - $43.82 $5,308 - $5,828	-133 Reduced 2.33%	5,578 $244,000
Q1 2023 Apr 27, 2023	BUY	$39.82 - $46.36 $1,752 - $2,039	44 Added 0.78%	5,711 $239,000
Q4 2022 Jan 23, 2023	BUY	$38.25 - $43.54 $7,764 - $8,838	203 Added 3.72%	5,667 $0
Q3 2022 Oct 28, 2022	SELL	$37.65 - $45.9 $16,791 - $20,471	-446 Reduced 7.55%	5,464 $206,000
Q2 2022 Jul 25, 2022	BUY	$37.88 - $48.01 $17,046 - $21,604	450 Added 8.24%	5,910 $230,000
Q1 2022 May 06, 2022	BUY	$44.42 - $51.73 $121,266 - $141,222	2,730 Added 100.0%	5,460 $259,000
Q3 2021 Oct 27, 2021	SELL	$48.3 - $52.49 $11,302 - $12,282	-234 Reduced 7.89%	2,730 $272,000
Q3 2020 Oct 29, 2020	BUY	$32.09 - $36.38 $95,114 - $107,830	2,964 New	2,964 $203,000

Others Institutions Holding SCHA

# of Institutions

1,119

Shares Held

230M

Call Options Held

44.7K

Put Options Held

32.4K

View Full List

About SCHWAB STRATEGIC TR US SMALL-C

Ticker SCHA
Sector ETFs
Industry ETFs

More about SCHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account